Clinical Trial Update: Feasibility of Prophylactic Haldol to Prevent Delirium in Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 feasibility trial evaluating prophylactic haloperidol (Haldol) to prevent delirium in cancer patients undergoing stem cell transplantation; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Delirium

Drugs mentioned

• Haldol (haloperidol)

Snippet

Sponsor: Michelle Weckmann | Conditions: Stem Cell Transplant Complications, Delirium | Phase 4 | Status: COMPLETED | Results posted: 2018-05-22